Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertensive nephrosclerosis: update.

Friedrich C Luft1

  • 1Franz Volhard Clinic, Medical Faculty of the Charité, HELIOS Klinikum, Berlin, Germany. luft@fvk-berlin.de

Current Opinion in Nephrology and Hypertension
|June 19, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulatory T cells ameliorate intrauterine growth retardation in a transgenic rat model for preeclampsia.

Hypertension (Dallas, Tex. : 1979)·2015
Same author

Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense.

Cell metabolism·2015
Same author

Approaching the Hayflick limit.

Trends in cardiovascular medicine·2015
Same author

Aortic stenosis is largely a boney affair.

Journal of molecular medicine (Berlin, Germany)·2015
Same author

Clinical salt deficits.

Pflugers Archiv : European journal of physiology·2014
Same author

C/EBPβ LIP induces a tumor menagerie making it an oncogene.

Journal of molecular medicine (Berlin, Germany)·2014

Angiotensin-converting enzyme inhibitors help slow kidney disease progression in African Americans with hypertension. Lowering blood pressure may benefit patients with proteinuria, and reduced glomerular number is linked to hypertension.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hypertension and diminished renal function are significant clinical concerns.
  • Understanding renal disease progression is crucial for effective treatment.
  • Recent studies offer insights into mechanisms and therapeutic strategies.

Purpose of the Study:

  • To review recent clinical trials and meta-analyses on blood pressure-lowering treatments for renal disease progression.
  • To discuss mechanistic studies in humans and animals related to kidney disease progression.
  • To synthesize current knowledge on hypertension management in patients with kidney disease.

Main Methods:

  • Analysis of a major clinical trial (African American Study of Kidney Disease and Hypertension).

Related Experiment Videos

  • Meta-analysis of studies on blood pressure targets in hypertensive patients.
  • Review of human autopsy and animal studies investigating renal structure and mechanisms.

    • Main Results:

    • Angiotensin-converting enzyme inhibitors showed superiority in slowing renal disease progression in African Americans compared to other agents.
    • Lowering blood pressure to <130/80 mmHg did not offer additional benefit over <140/90 mmHg in one trial.
    • A meta-analysis suggested benefits of lower blood pressure, especially in patients with proteinuria.
    • Studies indicated hypertensive individuals may have fewer, larger glomeruli, supported by animal models.
    • Smad7 transfer demonstrated potential in ameliorating renal damage in rats.

    Conclusions:

    • Current guidelines recommend angiotensin-converting enzyme inhibitors or angiotensin 1 receptor blockers for hypertensive patients with reduced renal function.
    • Evidence supports the theory of reduced glomerular number in essential hypertension and prenatal imprinting.
    • Advances in understanding basic mechanisms and novel therapies for renal disease progression are ongoing.